BAGGER RICHARD H
SEC Form 4 insider trading activity
BAGGER RICHARD H has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, BAGGER RICHARD H is listed as Director at Tonix Pharmaceuticals Holding Corp. Inside the rolling window, BAGGER RICHARD H reported 1 open-market purchase totaling $13K in TNXP and no open-market sales.
Companies traded
Other insiders at TNXP
Insider Buying
$13K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BAGGER RICHARD H made?
BAGGER RICHARD H has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does BAGGER RICHARD H trade?
BAGGER RICHARD H has filed SEC Form 4 disclosures for 1 company, including TNXP.
When was BAGGER RICHARD H's most recent SEC Form 4 filing?
BAGGER RICHARD H's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is BAGGER RICHARD H's total buy and sell value in the current window?
Inside the rolling retention window, BAGGER RICHARD H bought $13K and sold $0 based on SEC Form 4 filings.
What was BAGGER RICHARD H's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,000 TNXP shares on 2026-08-20, worth $13K, per SEC Form 4 filings.